Veteran technology executive will play instrumental role in guiding ArisGlobal’s future growth strategy MIAMI, FL June 11, 2020 – ArisGlobal, the leading provider of life sciences software that automates drug development functions for over 300 life sciences companies,...
ArisGlobal Announces the All-New LifeSphere® Regulatory Platform, Bringing Game-Changing Efficiency to Regulatory Information Management
LifeSphere Regulatory is a unified suite that delivers end-to-end regulatory information management to accelerate approvals, reduce risk and streamline collaboration. MIAMI, FL June 8, 2020 – ArisGlobal, the leading provider of software that automates core drug...
India’s Largest Biopharmaceutical Selects LifeSphere® eTMF to Streamline Clinical Trial Document Management
LifeSphere eTMF delivers easy and intuitive management of trial documentation to increase inspection readiness and reduce risk. MIAMI, FL May 13, 2020 – ArisGlobal, the leading provider of life sciences software that automates drug development functions for over 300...
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
Luye Pharma Group, an international pharmaceutical has selected LifeSphere Signal and Risk Management as its next-generation signal detection tool.
ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management
ArisGlobal announced the release of LifeSphere CTMS , a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes.
Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing
Two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliates
ArisGlobal to Co-Present “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology” at World Drug Safety Congress Americas
ArisGlobal is thrilled to announce their participation at the World Drug Safety Congress Americas, September 01 – 02, 2020. Along with a large drug manufacturer, they will be co-presenting a session titled “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology”.
ArisGlobal, is thrilled to be a Corporate Support Sponsor and to attend the SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando in Orlando, Florida from February 18 – 21, 2020, presented by the Cambridge Healthtech Institute.
ArisGlobal to Present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform” on Tuesday, February 11, 2020, at DIA Regulatory Submissions, Information and Document Management Forum (RSIDM).
Major Tobacco Manufacturer Selects LifeSphere® MultiVigilance to Automate All Global Internal Adverse Event Management Processes
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.